ZYVERSA THERAPEUTICS, INC. Prepaid Expense and Other Assets, Current
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Prepaid Expense and Other Assets, Current of $439.56 thousand as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-05-13
- 2026-03-31: Prepaid Expense and Other Assets, Current $439.56K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $347.19K; Prepaid Expense and Other Assets, Current as first filed $231.64K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $298.19K.
- 2025-06-30: Prepaid Expense and Other Assets, Current $378.75K.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-03-31 | $439.56K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $347.19K 10-Q · filed 2026-05-13 | $231.64K 10-K · filed 2026-03-31 |
| 2025-09-30 | $298.19K 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $378.75K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $498.78K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $184.87K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $267.49K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $521.91K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $866.48K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $215.46K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $426.52K 10-Q · filed 2023-11-14 | |
| 2022-12-31 | $225.35K 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |